Type III hypersensitivity reaction with the use of interferon-alpha.
Maurtua
M A
MA
Moscinski
L C
LC
Messina
J
J
Miller
L
L
Ballester
O F
OF
D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology* / Q000473:pathology; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000276:immunology*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D008875:Middle Aged; D011994:Recombinant Proteins; D012867:Skin / Q000276:immunology
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins